La. Sued Again Over Changes To US Drug Discount Program

By Theresa Schliep · September 21, 2023, 7:32 PM EDT

Drugmaker AbbVie Inc. hit Louisiana with a suit Thursday over requirements the state added to the controversial federal drug discount program, following another recent challenge to a law limiting Big Pharma's...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

AbbVie Inc et al v. Landry

Case Number

Court

Louisiana Western

Nature of Suit

Constitutional - State Statute

Date Filed

September 21, 2023

Recent Articles By Theresa

July 24, 2024
DC Circ. Nixes Medicare Hospital Inpatient Payment Rule
July 23, 2024
Kickback Risk Remains For Gene Therapy Fertility Programs
July 16, 2024
No Let-Up On DOJ Medicare Advantage Fraud Probes
July 09, 2024
Jarkesy Decision May Hit Key Healthcare Enforcement Tool
July 02, 2024
4 Takeaways From FDA's Clinical Trial Diversity Guidance
June 28, 2024
Health Regulators Likely To Tread Carefully Post-Chevron
June 25, 2024
Mich. Judge Blocks State Abortion Waiting Period, Counseling
June 25, 2024
In High Court Loss, Anti-Abortion Atty Sees Win For Objectors
June 18, 2024
Prelogar's Mifepristone Win Is 'A Master Class,' Advocates Say
June 13, 2024
Abortion Medication Case Ends 'With A Whimper' At High Court